Post Essential Thrombocythemia Myelofibrosis

Post-essential thrombocythemia myelofibrosis is a rare blood cancer that occurs as a complication of essential thrombocythemia. It is characterized by the development of fibrous tissue in the bone marrow, leading to the formation of blood cells outside the bone marrow. Symptoms may include fatigue, weakness, night sweats, and weight loss, and treatment options include chemotherapy, radiation therapy, and stem cell transplant.